CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing targeted therapies for colorectal cancer by utilizing molecular diagnostic assays to classify tumor subtypes. By conducting clinical studies, it aims to improve treatment efficacy based on specific genetic profiles, potentially benefiting a significant number of patients with poor pro…
Colorectal cancer (CRC) is increasingly being recognized as a heterogeneous disease with distinct molecular subtypes.
These subtypes have different biological processes at the basis of their disease and consequently their prognosis and responses to therapy are also different.We have previously developed molecular diagnostic assays using a single platform on routine FFPE tumour biopsies.
These assays identify gene expression profiles with distinct prognosis and drug response phenotypes (CMS4/c-ty…
FUNDACION PRIVADA INSTITUTO DEINVESTIGACION ONCOLOGICA DE VALL-HE
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALL-HEBRON (VHIO)
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Spain, Hospitalet de Llobregat
Type: Research institute
Activity type: Research Organisations
SME: No
Netherlands, AMSTERDAM
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Belgium, Bruxelles / Brussel
Type: Research institute
Activity type: Research Organisations
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
